Vascular Endothelial Growth Factor (VEGF) Levels and Mutation of the BRCA1 Gene in Breast Cancer Patients
Overview
Affiliations
The aim of the study was to compare VEGF serum levels in breast cancer patients with and without BRCA1 gene mutation. We enrolled 80 patients, 22 premenopausal and 58 postmenopausal. We found statistically significant lower levels of VEGF in patients with BRCA1 gene mutation as compared with breast cancer patients without this mutation.
High FSH levels impair VEGF secretion of human, frozen-thawed ovarian cortical tissue in vitro.
Einenkel R, Schallmoser A, Sanger N Sci Rep. 2024; 14(1):3287.
PMID: 38332226 PMC: 10853201. DOI: 10.1038/s41598-024-53402-8.
Wong H, Parkinson C, Ledermann J, Brenton J, Merger M, Shaw A Gynecol Oncol Case Rep. 2013; 3:7-10.
PMID: 24371652 PMC: 3862224. DOI: 10.1016/j.gynor.2012.10.003.
VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.
Saponaro C, Malfettone A, Ranieri G, Danza K, Simone G, Angelo Paradiso PLoS One. 2013; 8(1):e53070.
PMID: 23326384 PMC: 3543407. DOI: 10.1371/journal.pone.0053070.